While the role of GR expression and downstream gene expression pathways in cancer biology is still under investigation, many in vitro and in vivo models suggest that GR contributes to tumor chemoresistance through GR-driven transcriptional activation of pro-survival signaling pathways that prevent caspase-dependent apoptosis. Here, NR3C1 is linked to cancer.